Trials / Conditions / Multifocal Breast Carcinoma
Multifocal Breast Carcinoma
4 registered clinical trials studyying Multifocal Breast Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast C NCT04481113 | OHSU Knight Cancer Institute | Phase 1 |
| Active Not Recruiting | T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Br NCT04457596 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage NCT03128619 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients Wit NCT01272037 | National Cancer Institute (NCI) | Phase 3 |